Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.56 USD | -4.79% | +1.89% | -28.27% |
May. 09 | Transcript : InfuSystem Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | InfuSystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- With an expected P/E ratio at 75.6 and 19.14 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-28.27% | 161M | C- | ||
-4.91% | 182B | C+ | ||
+0.46% | 110B | C | ||
-3.62% | 67.92B | A | ||
+3.26% | 50.96B | B- | ||
+9.11% | 44.7B | B- | ||
+2.70% | 40.66B | B+ | ||
+6.39% | 27.6B | B | ||
+3.83% | 26.63B | A- | ||
+13.67% | 24.84B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INFU Stock
- Ratings InfuSystem Holdings, Inc.